KRAS and cancer: In addition, different pockets and domains that can accommodate compounds have been defined in the allosteric lobe and, interestingly, some of these compounds can inhibit KRAS signaling and reduce cancer cells’ viability or tumor progression in mouse models [16,33,34,35].